1)Device is a destination therapy (Chow)i.e.. its not a symptom relief device its far more powerful than that.
2) If you were offered C-Pulse 2 why wouldn't you (Texas Doc) Market penetration is going to be far higher than 6%
3)European Trial enrolment completed by or in Q3 (Basic groundwork done, people are being hired to keep the ball moving)
4)US trial. SSH has picked up the two big hitters in this space. It will finish enrolment substantially early. (Quite astounding the quality of people SSH is picking up and what these people are giving up in staff, status and pa's to be involved)
5)C-Pulse 2 not that long away, no battery, non obligatory, tet already tested, just have to prove the silicon works the same as air and a few design tweaks? bugs must be expected, cant see how it would be serious my fire pump looks more sophisticated.
6)Ramp up isn't going to be a problem. SSH is picking up the top notch, high achiever experienced people. Its not a small company trying to get big. Its a really big company squashed into a small room but not for long.
Pigs a 1,000 shares should cover things, a million $ in 5 years be alright.
Add to My Watchlist
What is My Watchlist?